On May 23, 2015, the seventh subject was treated in our ongoing study of MDMA-assisted therapy for social anxiety in 12 adults on the autism spectrum in Los Angeles, Calif. The eighth subject was enrolled on June 9. This study is exploring whether MDMA combined with therapy can enhance functional skills and quality of life in autistic adults with social anxiety. In addition to collecting data on the safety and effectiveness of MDMA-assisted therapy for reducing social anxiety in these subjects, researchers at Stanford University will also analyze blood plasma concentrations of several hormones (oxytocin, vasopressin, and cortisol) hypothesized to be involved in the therapeutic effectiveness of MDMA when combined with therapy. MDMA-autism.org
